Implementation of a Prescriptive Extracorporeal Circuit and Its Effect on Hemodilution and Blood Product Usage during Cardiac Surgery
Open Access
- 15 December 2020
- journal article
- research article
- Published by EDP Sciences in The Journal of ExtraCorporeal Technology
- Vol. 52 (4) , 295-302
Abstract
The use of cardiopulmonary bypass (CPB) contributes significantly to intraoperative anemia. The use of a prescriptive circuit that is tailored to the patient size could significantly reduce priming volumes, resulting in less hemodilution. The purpose of this study was to determine whether a prescriptive circuit resulted in decreased hemodilution, reduced blood product usage, and improved outcomes. In total, 204 patients prospectively received the prescriptive protocol between March 2019 and November 2019. This protocol was composed of three circuit sizes: small [body surface area (BSA) ≤ 1.85 m2], medium (BSA 1.86–2.30 m2), and large (BSA ≥ 2.31 m2). Data for CPB and post-bypass transfusions were collected, along with postoperative outcomes. These patients were then 1:2 propensity score matched to 401 patients who were retrospectively reviewed who had undergone cardiac surgery using a one-sized CPB circuit. The prescriptive protocol cohort had more patients with renal disease, whereas the conventional cohort had more history of hypertension. Intraoperative results show the prescriptive circuit had lower mean prime volume and total prime volume after reverse autologous prime (1,084 mL vs. 1,798 mL,p< .0001; 725 mL vs. 1,181 mL,p< .0001). Ultrafiltration was higher in the prescriptive group (872 vs. 645 mL,p< .0001), which likely balanced the increased use of del Nido cardioplegia in the prescriptive group (1,295 vs. 377 mL,p< .0001). The drop in hematocrit (HCT) from baseline was less in the prescriptive group (15.1 ± 4.91 vs. 16.2 ± 4.88,p= .0149), whereas the postoperative HCT was higher (32.79 ± 4.88 vs. 31.68 ± 4.99,p= .0069). Transfusion of packed red cells did not change between the two groups. Implementation of a prescriptive circuit did not reduce on-bypass or intraoperative blood product usage. However, there was a significant reduction in on-bypass hemodilution and increased postoperative HCT.Keywords
This publication has 19 references indexed in Scilit:
- Acute Kidney Injury and Hemodilution During Cardiopulmonary Bypass: A Changing ScenarioThe Annals of Thoracic Surgery, 2015
- The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both?The Journal of Thoracic and Cardiovascular Surgery, 2013
- Report from AmSECT’s International Consortium for Evidence-Based Perfusion: American Society of ExtraCorporeal Technology Standards and Guidelines for Perfusion Practice: 2013The Journal of ExtraCorporeal Technology, 2013
- Prescriptive Patient Extracorporeal Circuit and Oxygenator Sizing Reduces Hemodilution and Allogeneic Blood Product Transfusion during Adult Cardiac SurgeryThe Journal of ExtraCorporeal Technology, 2013
- A retrospective comparison of blood transfusion requirements during cardiopulmonary bypass with two different small adult oxygenatorsPerfusion, 2013
- Implications and management of anemia in cardiac surgery: Current state of knowledgeThe Journal of Thoracic and Cardiovascular Surgery, 2012
- 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice GuidelinesThe Annals of Thoracic Surgery, 2011
- Hematocrit on Cardiopulmonary Bypass and Outcome After Coronary Surgery in Nontransfused PatientsThe Annals of Thoracic Surgery, 2010
- Duration of Red-Cell Storage and Complications after Cardiac SurgeryNew England Journal of Medicine, 2008
- Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed?The Journal of Thoracic and Cardiovascular Surgery, 2003